Neptune Wellness Solutions Inc (NEPT)

[FUNMAN]

$8.34 Million in Sales Expected for Neptune Wellness Solutions Inc (NASDAQ:NEPT) This Quarter

Posted by Lars Charter on Dec 19th, 2019

https://rivertonroll.com/news/2019/12/19/8-34-million-in-sales-expected-for-neptune-wellness-solutions-inc-nasdaqnept-this-quarter.html

Equities analysts forecast that Neptune Wellness Solutions Inc (NASDAQ:NEPT) (TSE:NTB) will post sales of $8.34 million for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for Neptune Wellness Solutions’ earnings. The lowest sales estimate is $7.83 million and the highest is $8.85 million. Neptune Wellness Solutions posted sales of $4.95 million during the same quarter last year, which suggests a positive year-over-year growth rate of 68.5%. The company is expected to announce its next quarterly earnings report on Wednesday, February 12th.

According to Zacks, analysts expect that Neptune Wellness Solutions will report full year sales of $30.82 million for the current fiscal year, with estimates ranging from $27.95 million to $32.45 million. For the next fiscal year, analysts expect that the firm will post sales of $108.11 million, with estimates ranging from $102.52 million to $117.04 million. Zacks Investment Research’s sales averages are an average based on a survey of research analysts that that provide coverage for Neptune Wellness Solutions.

Neptune Wellness Solutions (NASDAQ:NEPT) (TSE:NTB) last announced its earnings results on Monday, November 11th. The biotechnology company reported ($0.17) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.04) by ($0.13). Neptune Wellness Solutions had a negative net margin of 187.60% and a negative return on equity of 39.61%. The company had revenue of $4.93 million for the quarter, compared to analysts’ expectations of $6.42 million.

NEPT has been the topic of a number of recent analyst reports. ValuEngine upgraded Neptune Wellness Solutions from a “hold” rating to a “buy” rating in a research note on Thursday, September 19th. BidaskClub upgraded shares of Neptune Wellness Solutions from a “strong sell” rating to a “sell” rating in a research note on Thursday, November 21st. TheStreet lowered shares of Neptune Wellness Solutions from a “c-” rating to a “d+” rating in a research note on Tuesday, October 15th. Desjardins reaffirmed a “buy” rating on shares of Neptune Wellness Solutions in a report on Wednesday, November 6th. Finally, Zacks Investment Research downgraded Neptune Wellness Solutions from a “hold” rating to a “sell” rating in a research note on Wednesday, September 25th. Two analysts have rated the stock with a sell rating and three have assigned a buy rating to the company’s stock. Neptune Wellness Solutions currently has an average rating of “Hold” and a consensus target price of $5.50.

Several institutional investors and hedge funds have recently made changes to their positions in NEPT. Morgan Stanley grew its stake in Neptune Wellness Solutions by 9.1% during the second quarter. Morgan Stanley now owns 208,980 shares of the biotechnology company’s stock valued at $909,000 after acquiring an additional 17,361 shares in the last quarter. Barclays PLC raised its stake in Neptune Wellness Solutions by 512.5% in the third quarter. Barclays PLC now owns 134,141 shares of the biotechnology company’s stock valued at $477,000 after purchasing an additional 112,241 shares in the last quarter. Penserra Capital Management LLC purchased a new stake in Neptune Wellness Solutions in the third quarter valued at approximately $166,000. Janney Montgomery Scott LLC purchased a new stake in Neptune Wellness Solutions in the third quarter valued at approximately $102,000. Finally, Jane Street Group LLC lifted its position in Neptune Wellness Solutions by 45.9% during the second quarter. Jane Street Group LLC now owns 22,598 shares of the biotechnology company’s stock valued at $98,000 after purchasing an additional 7,106 shares during the last quarter. Hedge funds and other institutional investors own 16.66% of the company’s stock.

NASDAQ NEPT traded up $0.01 on Friday, reaching $2.66. The company had a trading volume of 522,762 shares, compared to its average volume of 853,259. The stock has a market capitalization of $250.97 million, a P/E ratio of -19.00 and a beta of 1.75. The company’s fifty day moving average is $2.96 and its 200 day moving average is $4.03. Neptune Wellness Solutions has a 52-week low of $2.42 and a 52-week high of $6.57. The company has a quick ratio of 0.86, a current ratio of 1.10 and a debt-to-equity ratio of 0.01.

Neptune Wellness Solutions Company Profile

Neptune Wellness Solutions Inc, a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.